Torrent Pharmaceuticals Limited (BOM:500420)

Torrent Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	5,790	8,351	5,085	3,984	5,726
Short-Term Investments	1,120	279	581.6	5.9	264.2
Trading Asset Securities	-	1,410	1,561	1,840	1,390
Cash & Short-Term Investments	6,910	10,040	7,228	5,830	7,380
Cash Growth	-31.18%	38.91%	23.98%	-21.01%	11.43%
Accounts Receivable	18,670	18,443	19,438	16,325	15,234
Other Receivables	-	3,390	2,844	2,786	3,618
Receivables	18,720	21,863	22,300	19,137	18,883
Inventory	25,410	22,791	22,296	24,623	26,812
Prepaid Expenses	-	589.5	666.9	514.6	548
Restricted Cash	-	38.6	48	44.4	45.4
Other Current Assets	5,190	793	753.3	2,798	1,564
Total Current Assets	56,230	56,115	53,292	52,947	55,232
Property, Plant & Equipment	38,220	35,778	34,598	32,469	36,272
Long-Term Investments	440	332.9	711.1	679.2	681.2
Goodwill	3,390	3,380	3,375	2,595	3,412
Other Intangible Assets	42,630	45,828	50,895	35,461	39,855
Long-Term Deferred Tax Assets	5,950	5,551	5,437	4,937	4,217
Other Long-Term Assets	3,010	3,596	1,785	1,894	1,056
Total Assets	149,900	150,606	150,119	130,998	140,747
Accounts Payable	18,200	20,893	16,788	16,744	20,668
Accrued Expenses	-	3,784	3,690	3,111	3,324
Short-Term Debt	-	16,551	18,113	9,620	7,590
Current Portion of Long-Term Debt	18,340	6,959	10,360	9,718	11,800
Current Portion of Leases	300	200.6	183.3	147.3	264.7
Current Income Taxes Payable	960	1,679	313.1	414.8	539.9
Current Unearned Revenue	-	50	18.3	114.8	109.2
Other Current Liabilities	9,370	4,134	5,007	4,280	4,621
Total Current Liabilities	47,170	54,253	54,473	44,151	48,916
Long-Term Debt	11,920	16,038	24,962	21,232	29,411
Long-Term Leases	1,460	644.6	529.3	368.2	222
Long-Term Unearned Revenue	-	9.6	14.6	19.6	33
Long-Term Deferred Tax Liabilities	8,290	6,561	4,019	1,936	-
Other Long-Term Liabilities	5,150	3,703	3,351	2,865	2,762
Total Liabilities	73,990	82,044	88,138	71,469	82,375
Common Stock	1,690	1,692	1,692	846.2	846.2
Additional Paid-In Capital	-	-	-	43.4	43.4
Retained Earnings	-	67,908	61,159	57,739	55,905
Comprehensive Income & Other	74,220	-1,039	-870.5	900.6	1,577
Total Common Equity	75,910	68,562	61,981	59,530	58,372
Shareholders' Equity	75,910	68,562	61,981	59,530	58,372
Total Liabilities & Equity	149,900	150,606	150,119	130,998	140,747
Total Debt	32,020	40,394	54,148	41,086	49,287
Net Cash (Debt)	-25,110	-30,354	-46,921	-35,257	-41,907
Net Cash Per Share	-74.20	-89.69	-138.64	-104.17	-123.82
Filing Date Shares Outstanding	338.55	338.45	338.45	338.45	338.45
Total Common Shares Outstanding	338.55	338.45	338.45	338.45	338.45
Working Capital	9,060	1,862	-1,181	8,796	6,316
Book Value Per Share	224.22	202.58	183.13	175.89	172.47
Tangible Book Value	29,890	19,353	7,711	21,474	15,104
Tangible Book Value Per Share	88.29	57.18	22.78	63.45	44.63
Land	-	6,804	6,625	6,953	8,210
Buildings	-	14,910	11,343	11,698	10,149
Machinery	-	29,168	25,819	25,792	23,298
Construction In Progress	-	2,808	6,882	5,443	7,439

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.